Article thumbnail
Location of Repository

Therapeutic trials in muscular dystrophy. 1. Gold in murine dystrophy.

By A Enomoto and W G Bradley

Abstract

A trial of sodium aurothiomalate as an antiproteinase drug in the treatment of murine muscular dystrophy is reported. A blind controlled comparison of high (25 microgram/10 g body weight) and low dose gold (5 microgram/10 g body weight) with saline-injected control animals was made, all injections being given three times weekly. The body weights and functional ability of the mice were assessed at weekly intervals. No significant difference between the groups was observed. A trial of very high dose chrysotherapy (500 microgram of gold/10 g body weight) also showed no therapeutic benefit

Topics: Research Article
Year: 1978
DOI identifier: 10.1136/jnnp.41.5.404
OAI identifier: oai:pubmedcentral.nih.gov:493045
Provided by: PubMed Central
Sorry, our data provider has not provided any external links therefore we are unable to provide a link to the full text.

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.